600186.SS SHH
Lotus Health Group Company
1W: -11.4%
1M: -0.9%
3M: -6.5%
YTD: +90.0%
1Y: +85.7%
3Y: +285.9%
5Y: +332.4%
¥11.46 ($1.71)
-0.11 (-0.95%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$652M
+781.2% ▲
Capital Expenditures
$643M
-484.1% ▼
5Y CAGR: +250.5%
Free Cash Flow
$9M
+124.6% ▲
Dividends Paid
$29M
-6411.9% ▼
Buybacks
$73M
-599.7% ▼
Net Change in Cash
$488M
+1102.6% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $77M | $43M | $47M | $130M | $200M |
| Depreciation & Amort. | $11M | $11M | $18M | $16M | $71M |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$905M | -$4M | -$24M | -$84M | $322M |
| Other Non-Cash Items | $22M | $20M | $14M | $12M | $60M |
| Operating Cash Flow | -$794M | $70M | $55M | $74M | $652M |
| — Investing Activities — | |||||
| Capital Expenditures | -$90M | -$102M | -$42M | -$110M | -$643M |
| Acquisitions (Net) | $915K | $1M | $0 | $24M | $0 |
| Investment Purchases | $0 | -$9M | $0 | -$20M | -$5.8B |
| Investment Sales | $0 | -$1M | $0 | $0 | $5.7B |
| Other Investing | -$450K | $1M | $0 | -$24M | $46K |
| Investing Cash Flow | -$90M | -$109M | -$42M | -$130M | -$755M |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | -$350M | $18M | $92M | $585M |
| Stock Repurchased | $0 | -$976M | -$40M | -$10M | -$73M |
| Dividends Paid | -$21M | -$20M | -$5M | -$439K | -$29M |
| Other Financing | -$104M | $975M | $0 | -$22M | $96M |
| Financing Cash Flow | -$125M | $606M | -$27M | $73M | $591M |
| Net Change in Cash | -$1.0B | $566M | -$12M | $41M | $488M |
| Cash End of Period | $46M | $612M | $600M | $640M | $1.1B |
| Free Cash Flow | -$884M | -$31M | $13M | -$36M | $9M |